Comparison
3 Methylglutaconic Aciduria Type Viib C5676893 vs 3 4 Toe Cutaneous Syndactyly C5937396
Clinical comparison between 3 Methylglutaconic Aciduria Type Viib and 3 4 Toe Cutaneous Syndactyly for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria Type Viib C5676893
A rare genetic metabolic condition impacting mitochondria, similar to type VIIa. It causes neurological and developmental problems that require lifelong management. Treatment involves supportive therapies tailored to individual symptoms.
3 4 Toe Cutaneous Syndactyly C5937396
Skin webbing between the third and fourth toes, typically present at birth. Usually harmless and often left untreated unless it causes problems.
6 comparison axes
Onset
3 Methylglutaconic Aciduria Type Viib C5676893
0-5
3 4 Toe Cutaneous Syndactyly C5937396
0-0
Onset patterns differ
Severity
3 Methylglutaconic Aciduria Type Viib C5676893
severe
3 4 Toe Cutaneous Syndactyly C5937396
mild
Different severity levels
Chronic
3 Methylglutaconic Aciduria Type Viib C5676893
Chronic
3 4 Toe Cutaneous Syndactyly C5937396
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria Type Viib C5676893
No
3 4 Toe Cutaneous Syndactyly C5937396
No
Different transmission
Body System
3 Methylglutaconic Aciduria Type Viib C5676893
metabolic
3 4 Toe Cutaneous Syndactyly C5937396
musculoskeletal
Same/different system
Category
3 Methylglutaconic Aciduria Type Viib C5676893
metabolic
3 4 Toe Cutaneous Syndactyly C5937396
other
Different category
Bottom line
3-methylglutaconic-aciduria-type-viib-C5676893 and 3-4-toe-cutaneous-syndactyly-C5937396 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria Type Viib C5676893 | 3 4 Toe Cutaneous Syndactyly C5937396 | Discriminating power |
|---|---|---|---|
| Developmental or neurologic concerns | May include developmental delay or neurologic problems requiring ongoing care. | Not expected from isolated toe webbing. | High |
| Toe appearance | No established link to third-fourth toe skin webbing. | Skin connection between the third and fourth toes, typically from birth. | High |
| Systemic illness | A metabolic condition that may affect multiple body functions. | Usually a localized, harmless musculoskeletal finding. | Moderate |
When to favor each condition
Choose 3 Methylglutaconic Aciduria Type Viib C5676893 when
Early neurologic or developmental problems
Supports consideration of a rare metabolic disorder rather than an isolated toe finding.
Moderate
Abnormal organic-acid testing
An elevated 3-methylglutaconic acid result needs specialist interpretation and is not explained by syndactyly.
High
Suspected mitochondrial disease
Type VIIb belongs to a mitochondrial metabolic category and warrants genetics or metabolic evaluation.
Moderate
Choose 3 4 Toe Cutaneous Syndactyly C5937396 when
Isolated toe webbing at birth
The finding itself is the described condition and is usually mild.
High
No neurologic or metabolic concerns
Isolated syndactyly does not imply a metabolic diagnosis.
High
Local footwear or hygiene difficulty
Management, if needed, addresses the toe web rather than systemic disease.
Moderate
How key tests differ
| Test | 3 Methylglutaconic Aciduria Type Viib C5676893 | 3 4 Toe Cutaneous Syndactyly C5937396 | Interpretation |
|---|---|---|---|
| Physical examination | No specific toe finding is established. | Visible skin webbing between the third and fourth toes. | Examination can identify syndactyly but cannot diagnose Type VIIb. |
| Urine organic acids | May show 3-methylglutaconic acid elevation; exact cutoffs are not supplied. | No expected metabolic abnormality. | An abnormal result is not itself a complete diagnosis and needs clinician interpretation. |
| Genetic or metabolic evaluation | May be used to investigate the suspected rare disorder. | Not routinely needed for isolated cutaneous syndactyly. | Testing choice depends on the broader clinical picture. |
Prognosis comparison
3 Methylglutaconic Aciduria Type Viib C5676893
- Outcome
- Often requires lifelong supportive management; exact prognosis is not established.
- Factors
- Symptom severity, neurologic involvement, and response to supportive care.
3 4 Toe Cutaneous Syndactyly C5937396
- Outcome
- Usually benign, with or without treatment.
- Factors
- Functional impact, hygiene, footwear, and cosmetic concerns.
Time frame: Type VIIb may present in early childhood; syndactyly is typically present at birth.
Overall course should be judged individually because reliable outcome data are not supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic or developmental burden | Possible and may require lifelong supportive care. Not expected from isolated toe webbing. Specific complications and outcomes are not established here. |
| Local foot problems | No established association. May occasionally affect footwear, hygiene, or appearance. Many people need no treatment. |
| Need for procedures | No disease-specific procedure is established; care is supportive. Surgery may be considered only if webbing causes problems. Decisions require individual clinical assessment. |
Patient education highlights
- HighDifferent conditions
A metabolic disorder and toe webbing are unrelated findings unless a clinician identifies another cause.
- HighAbnormal test versus diagnosis
An organic-acid abnormality needs confirmation and specialist interpretation before a diagnosis is made.
- MediumWhen to seek care
Report developmental, neurologic, or feeding concerns promptly; seek foot care if webbing causes practical problems.